Medicines and Healthcare products Regulatory Agency
1: Authorisation Number | UK MIA 5866 |
---|---|
2: Name of authorisation holder | GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED |
3: Address(es) of manufacturing site(s) |
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED, THIRD AVENUE, HARLOW, CM19 5AW, UNITED KINGDOM |
4: Legally registered address of authorisation holder | GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED, GSK HOUSE, 980 GREAT WEST ROAD, BRENTFORD, TW8 9GS, UNITED KINGDOM |
5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
6: Legal Basis of authorisation | |
7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
8: Authorisation Date | 10/10/2024 |
9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 1
Name and address of the site:
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED, THIRD AVENUE, HARLOW, CM19 5AW, UNITED KINGDOM
Human Medicinal Products
Authorised Operations |
MANUFACTURING OPERATIONS (according to part 1)IMPORTATION OF MEDICINAL PRODUCTS (according to part 2) |
Part 1 - MANUFACTURING OPERATIONS |
[ 1.1 ] Sterile Products |
[ 1.1.3 ] Batch certification |
[ 1.2 ] Non-sterile products |
[ 1.2.2 ] Batch certification |
[ 1.3 ] Biological medicinal products |
[ 1.3.2 ] Batch certification |
[ 1.3.2.5 ] Biotechnology products |
[ 1.5 ] Packaging |
[ 1.5.1 ] Primary packaging |
[ 1.5.1.1 ] Capsules, hard shell |
[ 1.5.1.13 ] Tablets |
[ 1.5.2 ] Secondary packaging |
Part 2 - IMPORTATION OF MEDICINAL PRODUCTS |
[ 2.2 ] Batch certification of imported medicinal products |
[ 2.2.1 ] Sterile Products |
[ 2.2.1.1 ] Aseptically prepared |
[ 2.2.1.2 ] Terminally sterilised |
[ 2.2.2 ] Non-sterile products |
[ 2.2.3 ] Biological medicinal products |
[ 2.2.3.5 ] Biotechnology products |
[ 2.2.3.8 ] Other biological medicinal products Synthetic proteins |
[ 2.3 ] Other Importation Activities |
[ 2.3.1 ] Site of Physical Importation |
[ 2.3.2 ] Importation of Intermediate which undergoes further processing |